

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.91699526 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.86694748 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67656199 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.67656199 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.65320702 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32619059 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.32619059 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.92011705 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.33067783 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.31092878 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.31092878 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.31092878 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.16604721 |
| 14 | regulation of plasminogen activation (GO:0010755) | 6.08294737 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.01041594 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.93309471 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.86992319 |
| 18 | urea cycle (GO:0000050) | 5.67337610 |
| 19 | urea metabolic process (GO:0019627) | 5.67337610 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63017242 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.60828473 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.53778904 |
| 23 | ethanol metabolic process (GO:0006067) | 5.53777876 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.44098319 |
| 25 | protein carboxylation (GO:0018214) | 5.39176993 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39176993 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.39099588 |
| 28 | cysteine metabolic process (GO:0006534) | 5.37558348 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.35682271 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.34919692 |
| 31 | drug metabolic process (GO:0017144) | 5.28427954 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.21686124 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.15261101 |
| 34 | oxidative demethylation (GO:0070989) | 5.13375609 |
| 35 | bile acid metabolic process (GO:0008206) | 5.11112011 |
| 36 | regulation of complement activation (GO:0030449) | 5.03403753 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.02280232 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96459097 |
| 39 | negative regulation of blood coagulation (GO:0030195) | 4.93304808 |
| 40 | negative regulation of hemostasis (GO:1900047) | 4.93304808 |
| 41 | intestinal cholesterol absorption (GO:0030299) | 4.86826154 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.85463566 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.83671330 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.82777590 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.81063900 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.76988941 |
| 47 | acute-phase response (GO:0006953) | 4.76911930 |
| 48 | regulation of humoral immune response (GO:0002920) | 4.76649646 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.74553307 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.74553307 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.74553307 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.66241580 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.66241580 |
| 54 | negative regulation of protein activation cascade (GO:2000258) | 4.65838744 |
| 55 | * alpha-amino acid catabolic process (GO:1901606) | 4.62643746 |
| 56 | lysine catabolic process (GO:0006554) | 4.61328181 |
| 57 | lysine metabolic process (GO:0006553) | 4.61328181 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.60468398 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.57098424 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.57098424 |
| 61 | phospholipid efflux (GO:0033700) | 4.56447844 |
| 62 | positive regulation of blood coagulation (GO:0030194) | 4.54879912 |
| 63 | positive regulation of hemostasis (GO:1900048) | 4.54879912 |
| 64 | negative regulation of coagulation (GO:0050819) | 4.49158695 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.48379774 |
| 66 | regulation of apoptotic cell clearance (GO:2000425) | 4.46900061 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.46851356 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.45401825 |
| 69 | glycine metabolic process (GO:0006544) | 4.43729308 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.39946805 |
| 71 | opsonization (GO:0008228) | 4.38434716 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.38392390 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.37740837 |
| 74 | amine catabolic process (GO:0009310) | 4.37740837 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 4.34417887 |
| 76 | cellular glucuronidation (GO:0052695) | 4.29419194 |
| 77 | phenylpropanoid metabolic process (GO:0009698) | 4.27464906 |
| 78 | * cellular amino acid catabolic process (GO:0009063) | 4.25566827 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 4.22315769 |
| 80 | cholesterol efflux (GO:0033344) | 4.22275799 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.21540194 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.18648710 |
| 83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.16252115 |
| 84 | positive regulation of coagulation (GO:0050820) | 4.16182565 |
| 85 | ethanol oxidation (GO:0006069) | 4.15491785 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.11779303 |
| 87 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.07485097 |
| 88 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.07485097 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06211414 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 4.05652663 |
| 91 | * glutamate metabolic process (GO:0006536) | 4.05060919 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.04234782 |
| 93 | arginine metabolic process (GO:0006525) | 4.03976577 |
| 94 | fibrinolysis (GO:0042730) | 4.01640434 |
| 95 | protein-lipid complex subunit organization (GO:0071825) | 4.00342410 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.96676213 |
| 97 | drug catabolic process (GO:0042737) | 3.95756553 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95603052 |
| 99 | protein-lipid complex assembly (GO:0065005) | 3.94426809 |
| 100 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.86647479 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.85748670 |
| 102 | ketone body metabolic process (GO:1902224) | 3.85504068 |
| 103 | cofactor catabolic process (GO:0051187) | 3.82723615 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.81935521 |
| 105 | uronic acid metabolic process (GO:0006063) | 3.81935521 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81334352 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81334352 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.81290439 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78471932 |
| 110 | * imidazole-containing compound metabolic process (GO:0052803) | 3.76406830 |
| 111 | complement activation (GO:0006956) | 3.75203859 |
| 112 | negative regulation of complement activation (GO:0045916) | 3.74726066 |
| 113 | protein activation cascade (GO:0072376) | 3.73836987 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.73833974 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.73506004 |
| 116 | cytolysis (GO:0019835) | 3.73349443 |
| 117 | cholesterol homeostasis (GO:0042632) | 3.73082653 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72646596 |
| 119 | * carboxylic acid catabolic process (GO:0046395) | 3.72246979 |
| 120 | * organic acid catabolic process (GO:0016054) | 3.72246979 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.72092714 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.71085112 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.70354260 |
| 124 | sterol homeostasis (GO:0055092) | 3.66934892 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 3.65158594 |
| 126 | response to mercury ion (GO:0046689) | 3.62288879 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.62052069 |
| 128 | alkaloid metabolic process (GO:0009820) | 3.61997951 |
| 129 | plasma lipoprotein particle organization (GO:0071827) | 3.60988522 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57131484 |
| 131 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57131484 |
| 132 | acute inflammatory response (GO:0002526) | 3.53576696 |
| 133 | proline metabolic process (GO:0006560) | 3.51440985 |
| 134 | lipoprotein metabolic process (GO:0042157) | 3.47861939 |
| 135 | flavonoid metabolic process (GO:0009812) | 3.44994805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39340042 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20085299 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03077397 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51083845 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33661262 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07778782 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77987362 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07123922 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99974242 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05593587 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9935004 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97392614 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96084874 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60467123 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55273622 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51669048 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48981438 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40075654 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31162710 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29331350 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20843535 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18962769 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17340756 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08330038 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05979636 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03864446 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03107474 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02152017 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96155451 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92560521 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92323787 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86696028 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86181225 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85758032 |
| 35 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83878772 |
| 36 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83576118 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82478051 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79054174 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78158606 |
| 40 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77967090 |
| 41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77292165 |
| 42 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77036781 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77001709 |
| 44 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76209966 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75620597 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74578255 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74537901 |
| 48 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74010497 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72083083 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72021112 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68107518 |
| 52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.67678113 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67290848 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67240299 |
| 55 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64828996 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64822431 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64239535 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64239535 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.63878944 |
| 60 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63777286 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63561337 |
| 62 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.61946685 |
| 63 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61814204 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61567709 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.61171078 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61156221 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59956042 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59589483 |
| 69 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.58298545 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.58290876 |
| 71 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.57318192 |
| 72 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.57179980 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56998291 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.54567417 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54221670 |
| 76 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.54098932 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53622438 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53373486 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.53079055 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.53059935 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53014189 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52978748 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52925676 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52279592 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52112562 |
| 86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51544218 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51333602 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50982087 |
| 89 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.50895493 |
| 90 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.50706608 |
| 91 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.50534143 |
| 92 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50264902 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49100496 |
| 94 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48884274 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.48863305 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.48717000 |
| 97 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48436694 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47982745 |
| 99 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47686833 |
| 100 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.46998706 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.46392342 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46302761 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46244992 |
| 104 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.46184964 |
| 105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46131251 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45258859 |
| 107 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44874027 |
| 108 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43156551 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42753837 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42564664 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42348196 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42069154 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41895503 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41778103 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41685246 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41209784 |
| 117 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40747988 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39082827 |
| 119 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38984894 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38806931 |
| 121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38757053 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38689055 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38618112 |
| 124 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38178228 |
| 125 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36074125 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.35913653 |
| 127 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34845297 |
| 128 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34412418 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.33957130 |
| 130 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33885720 |
| 131 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33875226 |
| 132 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.33009557 |
| 133 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.32729812 |
| 134 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.32480365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31187443 |
| 2 | MP0005360_urolithiasis | 7.52826878 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46749299 |
| 4 | MP0005365_abnormal_bile_salt | 6.16969869 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14772043 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.31952641 |
| 7 | MP0003252_abnormal_bile_duct | 3.95108567 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59066153 |
| 9 | MP0009840_abnormal_foam_cell | 3.25602934 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10122850 |
| 11 | MP0003195_calcinosis | 2.89431561 |
| 12 | MP0005332_abnormal_amino_acid | 2.77276733 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60011717 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.32738546 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16578867 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12870408 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10574962 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.96243850 |
| 19 | MP0003868_abnormal_feces_composition | 1.88627058 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83145310 |
| 21 | MP0001764_abnormal_homeostasis | 1.66267682 |
| 22 | MP0009697_abnormal_copulation | 1.59246961 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56418832 |
| 24 | MP0000566_synostosis | 1.55431842 |
| 25 | MP0005451_abnormal_body_composition | 1.47211649 |
| 26 | MP0003011_delayed_dark_adaptation | 1.37440355 |
| 27 | MP0003186_abnormal_redox_activity | 1.26641307 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.26327923 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.23291906 |
| 30 | MP0003122_maternal_imprinting | 1.19132532 |
| 31 | MP0000598_abnormal_liver_morphology | 1.17694777 |
| 32 | MP0005647_abnormal_sex_gland | 1.17208425 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.14022798 |
| 34 | MP0001915_intracranial_hemorrhage | 1.12321797 |
| 35 | MP0009764_decreased_sensitivity_to | 1.07057927 |
| 36 | MP0003879_abnormal_hair_cell | 1.05987154 |
| 37 | MP0000604_amyloidosis | 1.05437437 |
| 38 | MP0002254_reproductive_system_inflammat | 1.03531272 |
| 39 | MP0009763_increased_sensitivity_to | 1.01624334 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.00777980 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 0.92794465 |
| 42 | MP0002282_abnormal_trachea_morphology | 0.88842951 |
| 43 | MP0008469_abnormal_protein_level | 0.88701803 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.86978722 |
| 45 | MP0005408_hypopigmentation | 0.84669437 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.81952587 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.81728920 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.79964861 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.78235416 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.77879308 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.77299136 |
| 52 | MP0002249_abnormal_larynx_morphology | 0.77199424 |
| 53 | MP0002089_abnormal_postnatal_growth/wei | 0.75333707 |
| 54 | MP0005670_abnormal_white_adipose | 0.74346254 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.72921371 |
| 56 | MP0002971_abnormal_brown_adipose | 0.71990579 |
| 57 | MP0005334_abnormal_fat_pad | 0.69434014 |
| 58 | MP0005535_abnormal_body_temperature | 0.67569911 |
| 59 | MP0004130_abnormal_muscle_cell | 0.66190323 |
| 60 | MP0003690_abnormal_glial_cell | 0.66139280 |
| 61 | MP0003172_abnormal_lysosome_physiology | 0.65870533 |
| 62 | MP0005266_abnormal_metabolism | 0.65630740 |
| 63 | MP0001661_extended_life_span | 0.64345113 |
| 64 | MP0009053_abnormal_anal_canal | 0.63504535 |
| 65 | MP0003329_amyloid_beta_deposits | 0.60765511 |
| 66 | MP0001756_abnormal_urination | 0.58968289 |
| 67 | MP0006292_abnormal_olfactory_placode | 0.58735188 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.58624535 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.58077277 |
| 70 | MP0005448_abnormal_energy_balance | 0.54511427 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.52536724 |
| 72 | MP0002822_catalepsy | 0.50030278 |
| 73 | MP0002928_abnormal_bile_duct | 0.48678575 |
| 74 | MP0005395_other_phenotype | 0.48488107 |
| 75 | MP0003724_increased_susceptibility_to | 0.47498965 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.46358874 |
| 77 | MP0003718_maternal_effect | 0.45988208 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.45806215 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.45509479 |
| 80 | MP0008874_decreased_physiological_sensi | 0.45423362 |
| 81 | MP0005023_abnormal_wound_healing | 0.45252478 |
| 82 | MP0003436_decreased_susceptibility_to | 0.43734457 |
| 83 | MP0004381_abnormal_hair_follicle | 0.43187600 |
| 84 | MP0008873_increased_physiological_sensi | 0.42782722 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.41859736 |
| 86 | MP0005187_abnormal_penis_morphology | 0.41707360 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 0.41328092 |
| 88 | MP0003075_altered_response_to | 0.40969285 |
| 89 | MP0003953_abnormal_hormone_level | 0.40489302 |
| 90 | MP0005166_decreased_susceptibility_to | 0.40102598 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.39806002 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.38449260 |
| 93 | MP0003878_abnormal_ear_physiology | 0.38449260 |
| 94 | MP0005409_darkened_coat_color | 0.38262619 |
| 95 | MP0003123_paternal_imprinting | 0.37242894 |
| 96 | MP0008872_abnormal_physiological_respon | 0.37218249 |
| 97 | MP0000579_abnormal_nail_morphology | 0.35882745 |
| 98 | MP0009672_abnormal_birth_weight | 0.35521590 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.35157430 |
| 100 | MP0006082_CNS_inflammation | 0.34525817 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.33684753 |
| 102 | MP0002796_impaired_skin_barrier | 0.32658348 |
| 103 | MP0009115_abnormal_fat_cell | 0.31779119 |
| 104 | MP0000249_abnormal_blood_vessel | 0.31424464 |
| 105 | MP0004883_abnormal_blood_vessel | 0.31153857 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.31150521 |
| 107 | MP0002168_other_aberrant_phenotype | 0.31133929 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.30338918 |
| 109 | MP0002132_abnormal_respiratory_system | 0.30112962 |
| 110 | MP0001243_abnormal_dermal_layer | 0.30036494 |
| 111 | MP0002970_abnormal_white_adipose | 0.29688259 |
| 112 | MP0009785_altered_susceptibility_to | 0.29445709 |
| 113 | MP0001853_heart_inflammation | 0.29357193 |
| 114 | MP0003699_abnormal_female_reproductive | 0.27793827 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.27453418 |
| 116 | MP0001881_abnormal_mammary_gland | 0.27210127 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.27110162 |
| 118 | MP0004272_abnormal_basement_membrane | 0.26798608 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.26130054 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.25911204 |
| 121 | MP0005164_abnormal_response_to | 0.24897996 |
| 122 | MP0002060_abnormal_skin_morphology | 0.23270711 |
| 123 | MP0003632_abnormal_nervous_system | 0.23070297 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.22616937 |
| 125 | MP0000920_abnormal_myelination | 0.22335680 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.22112632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.41083234 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.34596783 |
| 3 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.93791044 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71520608 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.60568336 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.40771258 |
| 7 | Xanthomatosis (HP:0000991) | 6.27430101 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.57417710 |
| 9 | Complement deficiency (HP:0004431) | 5.45430750 |
| 10 | Joint hemorrhage (HP:0005261) | 4.83588100 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.78189927 |
| 12 | Hyperammonemia (HP:0001987) | 4.59290503 |
| 13 | Epidermoid cyst (HP:0200040) | 4.48981581 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48974659 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.48185484 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36510253 |
| 17 | Ketosis (HP:0001946) | 4.28023579 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.26049228 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24945724 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.19068969 |
| 21 | Fat malabsorption (HP:0002630) | 4.15760862 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13859906 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11386446 |
| 24 | Abnormality of complement system (HP:0005339) | 3.97628479 |
| 25 | Hyperglycinuria (HP:0003108) | 3.95866309 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.95775945 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95775945 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.88043890 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83964483 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78368183 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76743979 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.60685192 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37431154 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34798064 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.34178994 |
| 36 | Steatorrhea (HP:0002570) | 3.15744113 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.12832648 |
| 38 | Spontaneous abortion (HP:0005268) | 3.12443953 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.08965608 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07343181 |
| 41 | Myocardial infarction (HP:0001658) | 3.03873661 |
| 42 | Ketoacidosis (HP:0001993) | 3.02066269 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 3.01753276 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.00807256 |
| 45 | Purpura (HP:0000979) | 2.90391508 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.79560623 |
| 47 | Metabolic acidosis (HP:0001942) | 2.77454774 |
| 48 | Skin nodule (HP:0200036) | 2.75845607 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.69032530 |
| 50 | Vascular calcification (HP:0004934) | 2.64159596 |
| 51 | Lethargy (HP:0001254) | 2.58971916 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.58465894 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58465894 |
| 54 | Osteomalacia (HP:0002749) | 2.58078713 |
| 55 | Acanthocytosis (HP:0001927) | 2.51526054 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.50052035 |
| 57 | Gout (HP:0001997) | 2.49669166 |
| 58 | Mitral stenosis (HP:0001718) | 2.49545020 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.48332024 |
| 60 | Fair hair (HP:0002286) | 2.48036593 |
| 61 | Spastic diplegia (HP:0001264) | 2.45706299 |
| 62 | Cholelithiasis (HP:0001081) | 2.42643301 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41355414 |
| 64 | Glomerulonephritis (HP:0000099) | 2.40113792 |
| 65 | Cerebral edema (HP:0002181) | 2.39648399 |
| 66 | Neonatal onset (HP:0003623) | 2.37342959 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.35291166 |
| 68 | Cholecystitis (HP:0001082) | 2.35291166 |
| 69 | Malnutrition (HP:0004395) | 2.34712230 |
| 70 | Irritability (HP:0000737) | 2.34617260 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.34106742 |
| 72 | Amyloidosis (HP:0011034) | 2.32356026 |
| 73 | Pulmonary embolism (HP:0002204) | 2.25000956 |
| 74 | Gingival bleeding (HP:0000225) | 2.23411528 |
| 75 | Esophageal varix (HP:0002040) | 2.18678630 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.17792903 |
| 77 | Enlarged kidneys (HP:0000105) | 2.14826758 |
| 78 | Menorrhagia (HP:0000132) | 2.14756521 |
| 79 | Brushfield spots (HP:0001088) | 2.14489105 |
| 80 | Pancreatitis (HP:0001733) | 2.13965175 |
| 81 | Late onset (HP:0003584) | 2.13418469 |
| 82 | Thrombophlebitis (HP:0004418) | 2.12284570 |
| 83 | Bifid scrotum (HP:0000048) | 2.09424538 |
| 84 | Vomiting (HP:0002013) | 2.07926351 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.07584503 |
| 86 | Generalized aminoaciduria (HP:0002909) | 2.06693429 |
| 87 | Opisthotonus (HP:0002179) | 2.06647554 |
| 88 | Poikilocytosis (HP:0004447) | 2.03286772 |
| 89 | Neonatal hypoglycemia (HP:0001998) | 2.03154421 |
| 90 | Abnormality of the gallbladder (HP:0005264) | 2.02531480 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02305220 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 1.98058833 |
| 93 | Rickets (HP:0002748) | 1.98046793 |
| 94 | Arthropathy (HP:0003040) | 1.93721440 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 1.92703614 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.91374640 |
| 97 | Renal cortical cysts (HP:0000803) | 1.88806406 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88781852 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.86847156 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.85795126 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 1.85795126 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82575847 |
| 103 | Elevated hepatic transaminases (HP:0002910) | 1.82405620 |
| 104 | Alkalosis (HP:0001948) | 1.81340688 |
| 105 | Status epilepticus (HP:0002133) | 1.80895185 |
| 106 | Epistaxis (HP:0000421) | 1.76484865 |
| 107 | Hyperglycemia (HP:0003074) | 1.74053710 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.74052451 |
| 109 | Hyperphosphaturia (HP:0003109) | 1.73854575 |
| 110 | Gangrene (HP:0100758) | 1.73405675 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.72365038 |
| 112 | Joint swelling (HP:0001386) | 1.72265730 |
| 113 | Nephritis (HP:0000123) | 1.71607549 |
| 114 | Increased serum pyruvate (HP:0003542) | 1.67881006 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 1.67814917 |
| 116 | Increased serum ferritin (HP:0003281) | 1.66731841 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.64407594 |
| 118 | Reticulocytosis (HP:0001923) | 1.63433693 |
| 119 | Abnormal tarsal ossification (HP:0008369) | 1.61683016 |
| 120 | Increased mean platelet volume (HP:0011877) | 1.61531644 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.59717474 |
| 122 | Potter facies (HP:0002009) | 1.59247416 |
| 123 | Facial shape deformation (HP:0011334) | 1.59247416 |
| 124 | Glycosuria (HP:0003076) | 1.56217696 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 1.56217696 |
| 126 | Abnormal delivery (HP:0001787) | 1.54605018 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.54411517 |
| 128 | Blue irides (HP:0000635) | 1.53255978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.06875205 |
| 2 | FGFR4 | 4.72265384 |
| 3 | SIK1 | 4.62810673 |
| 4 | ERN1 | 4.52292545 |
| 5 | TAOK3 | 3.14364593 |
| 6 | INSRR | 3.10871355 |
| 7 | ERBB4 | 3.00992511 |
| 8 | MAP2K4 | 2.32504177 |
| 9 | CDK12 | 2.14353009 |
| 10 | PKN2 | 2.08714900 |
| 11 | NTRK3 | 2.07045739 |
| 12 | MST1R | 2.03441516 |
| 13 | MAPK11 | 1.91807881 |
| 14 | WNK4 | 1.86772650 |
| 15 | PIK3CG | 1.85531555 |
| 16 | FLT3 | 1.84031339 |
| 17 | TYK2 | 1.71646047 |
| 18 | TRIB3 | 1.71374705 |
| 19 | LATS1 | 1.62860940 |
| 20 | DAPK2 | 1.57553075 |
| 21 | PDGFRA | 1.51011887 |
| 22 | PTK6 | 1.48547811 |
| 23 | NEK9 | 1.43931508 |
| 24 | ABL2 | 1.43836895 |
| 25 | FGFR1 | 1.39786319 |
| 26 | FGFR2 | 1.34589241 |
| 27 | TYRO3 | 1.33615390 |
| 28 | FRK | 1.29656017 |
| 29 | KDR | 1.27958465 |
| 30 | AKT3 | 1.23864749 |
| 31 | JAK2 | 1.22822271 |
| 32 | MAP3K7 | 1.22075285 |
| 33 | MAP3K2 | 1.17168544 |
| 34 | PINK1 | 1.14646780 |
| 35 | MAP2K3 | 1.11234670 |
| 36 | PRKAA2 | 1.11065665 |
| 37 | MAPK15 | 1.08967321 |
| 38 | TBK1 | 1.05083489 |
| 39 | ERBB2 | 1.04966635 |
| 40 | GRK6 | 1.04642655 |
| 41 | JAK1 | 1.03022973 |
| 42 | MAP3K14 | 1.02985247 |
| 43 | SIK2 | 1.02705267 |
| 44 | MAP3K10 | 0.97480038 |
| 45 | MAPK4 | 0.95448821 |
| 46 | PRPF4B | 0.93123278 |
| 47 | PIM2 | 0.92894539 |
| 48 | STK38L | 0.92361317 |
| 49 | PRKCZ | 0.91438150 |
| 50 | MAP3K3 | 0.86396982 |
| 51 | EPHB1 | 0.85554664 |
| 52 | EPHA2 | 0.84196479 |
| 53 | TIE1 | 0.81149674 |
| 54 | MET | 0.81091810 |
| 55 | CDK6 | 0.80689328 |
| 56 | MAPK12 | 0.79097754 |
| 57 | EPHA3 | 0.78535114 |
| 58 | MAP3K11 | 0.76433039 |
| 59 | SGK1 | 0.74123219 |
| 60 | PRKACG | 0.73595035 |
| 61 | DYRK1B | 0.72784800 |
| 62 | STK38 | 0.72512549 |
| 63 | CAMK2G | 0.71500415 |
| 64 | CSK | 0.71111518 |
| 65 | CSNK1E | 0.70595982 |
| 66 | PRKG1 | 0.69624981 |
| 67 | IRAK3 | 0.68632481 |
| 68 | GSK3A | 0.67704934 |
| 69 | MAP2K6 | 0.67433396 |
| 70 | WNK1 | 0.67090780 |
| 71 | CAMK1D | 0.66480173 |
| 72 | SGK3 | 0.65777639 |
| 73 | EEF2K | 0.65134690 |
| 74 | PRKAA1 | 0.64706798 |
| 75 | DDR2 | 0.64177653 |
| 76 | TGFBR2 | 0.60676726 |
| 77 | RIPK1 | 0.59633606 |
| 78 | SMG1 | 0.59017031 |
| 79 | MAPK7 | 0.57801925 |
| 80 | FGFR3 | 0.57222605 |
| 81 | PTK2 | 0.56647450 |
| 82 | CSNK1D | 0.55702771 |
| 83 | IKBKE | 0.55266829 |
| 84 | CDK7 | 0.55231088 |
| 85 | CSF1R | 0.53240433 |
| 86 | PRKACA | 0.52319520 |
| 87 | MAPKAPK3 | 0.51925396 |
| 88 | KSR2 | 0.51168277 |
| 89 | PRKCQ | 0.50964597 |
| 90 | SGK2 | 0.50783108 |
| 91 | TAOK2 | 0.50359810 |
| 92 | PDPK1 | 0.49859369 |
| 93 | CSNK1G1 | 0.47809655 |
| 94 | GRK1 | 0.47632354 |
| 95 | EPHA4 | 0.47251174 |
| 96 | RPS6KA3 | 0.46871577 |
| 97 | RPS6KB1 | 0.46515348 |
| 98 | MAP3K9 | 0.45587766 |
| 99 | SRC | 0.45234008 |
| 100 | PKN1 | 0.45196565 |
| 101 | MAP3K5 | 0.45043943 |
| 102 | CDC42BPA | 0.42888476 |
| 103 | IGF1R | 0.42630631 |
| 104 | PDK2 | 0.42528700 |
| 105 | MAP3K13 | 0.41387959 |
| 106 | NLK | 0.41380781 |
| 107 | CDK4 | 0.41017515 |
| 108 | MARK2 | 0.40279944 |
| 109 | MAP2K1 | 0.39214537 |
| 110 | CDK9 | 0.38943490 |
| 111 | PRKCG | 0.38465467 |
| 112 | RET | 0.37872698 |
| 113 | ARAF | 0.37466823 |
| 114 | MAP3K6 | 0.36999009 |
| 115 | SGK494 | 0.36225489 |
| 116 | SGK223 | 0.36225489 |
| 117 | CSNK2A1 | 0.36136111 |
| 118 | ICK | 0.36118683 |
| 119 | MTOR | 0.34166059 |
| 120 | CSNK2A2 | 0.33843887 |
| 121 | CAMK4 | 0.33645177 |
| 122 | EGFR | 0.32855828 |
| 123 | PBK | 0.31920341 |
| 124 | MAP3K1 | 0.30795166 |
| 125 | MAPK3 | 0.30613209 |
| 126 | ZAP70 | 0.29313821 |
| 127 | EIF2AK1 | 0.29230766 |
| 128 | PRKACB | 0.29119331 |
| 129 | PRKCB | 0.29017321 |
| 130 | PDK1 | 0.28561442 |
| 131 | CSNK1G2 | 0.27515626 |
| 132 | MAPK10 | 0.26980445 |
| 133 | MAPK1 | 0.26799025 |
| 134 | IRAK1 | 0.26372662 |
| 135 | PRKCA | 0.25368480 |
| 136 | LATS2 | 0.24193740 |
| 137 | CSNK1G3 | 0.24115611 |
| 138 | IRAK2 | 0.23546845 |
| 139 | CAMK1G | 0.23373787 |
| 140 | ABL1 | 0.21573723 |
| 141 | PAK3 | 0.21155336 |
| 142 | CSNK1A1L | 0.19901980 |
| 143 | MAP2K2 | 0.19250389 |
| 144 | PIK3CA | 0.18017363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.57156997 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52261527 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37012547 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35674177 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07102439 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79038696 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72433966 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69449845 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64729100 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57118439 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50158181 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39336793 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27655184 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17351182 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14829528 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.10073521 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95711243 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93880173 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92957993 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91780454 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86228323 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80394021 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78360506 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77068595 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74472239 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73361670 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72974787 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71571501 |
| 29 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.69868250 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65516263 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61806419 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61128427 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56517336 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52047817 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49989168 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49253217 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47151787 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36516766 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35097717 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32940960 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31981827 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27917707 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22528330 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21754622 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19554061 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19518218 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14818218 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11621434 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05553752 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03099922 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02281505 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01674701 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98628350 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96831163 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96131226 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88201600 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85582531 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85220322 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82242954 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69998313 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67054151 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66008487 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54987035 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52617938 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45674358 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45647937 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41961406 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.41283590 |
| 69 | * One carbon pool by folate_Homo sapiens_hsa00670 | 0.40127282 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.38763615 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38531969 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26563298 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26359591 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23628640 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22879170 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21682323 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21378930 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17866502 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15907955 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.11317478 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10213231 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01432680 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2415515 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2377606 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2348380 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2344580 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2328413 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2295529 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2247684 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2076513 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1999639 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1943620 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1928890 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1680743 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1649972 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1549612 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1518944 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1465549 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1374111 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1370327 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1286085 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1161829 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1024872 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0881267 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0805199 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0786886 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0572929 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0438662 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0356826 |

